Cervical Cancer


FirstHealth Makes History Enrolling the First Patient in Immunotherapy Clinical Trial Addressing Cervical Cancer

FirstHealth of the Carolinas enrolled the first patient in a worldwide clinical trial testing the efficacy and safety of immune therapies designed to battle cervical cancer. Selected by sponsors’ GOG Foundation, Inc. and Agenus Inc. for the multi-national clinical...

Inovio Pharmaceuticals Phase 3 HPV Immunotherapy Vaccine Receives “Best Therapeutic Vaccine” at World Vaccine Congress

Inovio Pharmaceuticals announced  VGX-3100, its Phase 3 immunotherapy to treat cervical dysplasia, was selected for the "Best Therapeutic Vaccine" award at the World Vaccine Congress held in Washington, D.C. Each year, the Vaccine Industry Excellence (ViE) award...

Pin It on Pinterest